<DOC>
	<DOCNO>NCT02022826</DOCNO>
	<brief_summary>This protocol design validate use SPM diagnosis delay gastric empty patient symptoms gastroparesis assess impact SmartPill study patient management gastroparetic population . Patients symptoms gastroparesis recruit . Patients undergo concurrent gastric scintigraphy SPM test determine presence absence delay gastric empty base predetermine diagnostic cutoff technique .</brief_summary>
	<brief_title>Clinical Management With SPM System Validation SPM 5 Hour Cutoff Patients With Symptoms Gastroparesis</brief_title>
	<detailed_description />
	<mesh_term>Gastroparesis</mesh_term>
	<criteria>Males female age 1880 year age symptoms gastroparesis least 12 week . Presenting 2 follow symptom sign , opinion site investigator , suggestive diagnosis gastroparesis : 1 Nausea , vomit , retch ( dry heave ) 2 Postprandial fullness early satiety 3 Bloating visible abdominal distention 4 Postprandial discomfort pain Ability stop proton pump inhibitor 7 day histamine2 receptor antagonist , prokinetic agent , narcotic agent , anticholinergic drug , cannabinoids 3 day prior SPM gastric scintigraphy test . No evidence metabolic disease ( hypothyroidism , uncontrolled diabetes [ hemoglobin A1c &gt; 10 % within past 6 month ] , electrolyte imbalance ) . An upper endoscopy upper gastrointestinal barium series within past 2 year show organic disease potentially causative symptom . High probability compliance completion study . Participation previous SmartPill clinical trial . Previous history bezoars ( presence retain liquid , bile , small amount poorly organize food residue permit ) . Dysphagia solid food pill . Prior surgery involve luminal gastrointestinal tract ( cholecystectomy , appendectomy , hysterectomy permit perform &gt; 3 month prior SPM test ) . Any abdominal pelvic surgery within past 3 month Known history inflammatory bowel disease . History diverticulitis , diverticular stricture , intestinal stricture . Chronic daily use nonsteroidal antiinflammatory drug ( ibuprofen , naproxen , etc . ) Tobacco alcohol use within eight hour prior capsule ingestion . BMI &gt; 40 kg/m2 . Allergies egg , bread , jam . Females childbearing age practice birth control and/or pregnant lactating . ( Urine pregnancy test perform female subject childbearing potential prior capsule ingestion gastric scintigraphy ) . Use cardiac medical device pacemaker defibrillator ( gastric stimulators , bladder stimulators , spinal stimulators , medication infusion device , insulin pump , continuous glucose monitor permit ) . Uncontrolled diabetes hemoglobin A1c &gt; 10 % . Patient expect undergo MRI examination within 7 day ingestion capsule</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Gastroparesis</keyword>
	<keyword>SmartPill Monitoring System ( SPM )</keyword>
	<keyword>Gastric Emptying Scintigraphy ( GES )</keyword>
</DOC>